Table 2.
Description of antibiotic treatment for UTIs and characteristics of residents receiving antibiotics
| France | Greece | Lithuania | Poland | Spain | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | |
| Total antibiotic use | 135 | 73 | 176 | 428 | 399 | 1211 | ||||||
| Here antibiotic use for UTI | 55 | (40.7) | 17 | (23.3) | 43 | (24.4) | 156 | (36.4) | 237 | (59.4) | 508 | (41.9) |
| Age of resident receiving antibiotic for UTI | ||||||||||||
| Under 85 | 10 | (18.2) | 4 | (23.5) | 34 | (79.1) | 120 | (76.9) | 76 | (32.1) | 244 | (48.0) |
| 85 + | 45 | (81.8) | 13 | (76.5) | 9 | (20.9) | 36 | (23.1) | 161 | (67.9) | 264 | (52.0) |
| Total | 55 | (100) | 17 | (100) | 43 | (100) | 156 | (100) | 237 | (100) | 508 | (100) |
| Sex | ||||||||||||
| Female | 45 | (81.8) | 13 | (76.5) | 26 | (60.5) | 96 | (61.5) | 199 | (84.0) | 379 | (74.6) |
| Type of treatment | ||||||||||||
| Start-up treatment | 47 | (85.5) | 14 | (82.4) | 32 | (74.4) | 134 | (85.9) | 215 | (90.7) | 442 | (87.0) |
| Prophylaxis | 2 | (3.6) | 3 | (17.6) | 1 | (2.3) | 4 | (2.6) | 8 | (3.4) | 18 | (3.5) |
| Extension of current treatment | 6 | (10.9) | 0 | (0) | 9 | (20.9) | 16 | (10.3) | 10 | (4.2) | 41 | (8.1) |
| Unknown | 0 | (0) | 0 | (0) | 0 | (0) | 2 | (1.3) | 3 | (1.3) | 5 | (1.0) |
| Missing | 0 | (0) | 0 | (0) | 1 | (2.3) | 0 | (0) | 1 | (0.4) | 2 | (0.4) |
| Total | 55 | (100) | 17 | (100) | 43 | (100) | 156 | (100) | 237 | (100) | 508 | (100) |
| Indwelling urinary catheter | ||||||||||||
| Yes | 5 | (9.1) | 14 | (82.4) | 17 | (39.5) | 71 | (45.5) | 20 | (8.4) | 127 | (25) |
| No | 50 | (90.9) | 3 | (17.6) | 23 | (53.5) | 85 | (54.5) | 215 | (90.7) | 376 | (74.0) |
| Missing | 0 | (0) | 0 | (0) | 3 | (7) | 0 | (0) | 2 | (0.8) | 5 | (1) |
| Total | 55 | (100) | 17 | (100) | 43 | (100) | 156 | (100) | 237 | (100) | 508 | (100) |
| Type of antibiotic* | ||||||||||||
| Penicillin V or pivmecillinam | 5 | (9.1) | 1 | (5.9) | 0 | (0) | 0 | (0) | 0 | (0) | 6 | (1.2) |
| Amoxicillin | 5 | (9.1) | 0 | (0) | 1 | (2.3) | 0 | (0) | 4 | (1.7) | 10 | (2.0) |
| Amoxicillin + clavulanic acid | 1 | (1.8) | 0 | (0) | 3 | (7) | 11 | (7.1) | 26 | (11) | 41 | (8.1) |
| Fosfomycin | 12 | (21.8) | 1 | (5.9) | 0 | (0) | 5 | (3.2) | 119 | (50.2) | 137 | (27) |
| Nitrofurantoin | 4 | (7.3) | 0 | (0) | 20 | (46.5) | 56 | (35.9) | 8 | (3.4) | 88 | (17.3) |
| Trimethoprim ± sulfonamide | 5 | (9.1) | 0 | (0) | 4 | (9.3) | 3 | (1.9) | 7 | (3) | 19 | (3.7) |
| Macrolides or clindamycin | 2 | (3.6) | 0 | (0) | 0 | (0) | 4 | (2.6) | 1 | (0.4) | 7 | (1.4) |
| Cephalosporins | 15 | (27.3) | 5 | (29.4) | 12 | (27.9) | 5 | (3.2) | 29 | (12.2) | 66 | (13.0) |
| Quinolones | 7 | (12.7) | 6 | (35.3) | 6 | (14) | 64 | (41) | 33 | (13.9) | 116 | (22.8) |
| Other antibiotics | 0 | (0) | 4 | (23.5) | 1 | (2.3) | 36 | (23.1) | 13 | (5.5) | 54 | (10.6) |
*More than one antibiotic may be prescribed; therefore, columns may summarize to more than 100%